Lead sponsor
Tetra Discovery Partners
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
0
Ongoing
402
Total enrollment
43
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
3
Phase 2
1
Trials by status
Completed
4
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's SubjectsAlzheimer's diseasePh 2Completed255
A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female SubjectsAge 25-90Ph 1Completed77